Pulse Therapeutics is proud to announce its merger with ICHOR Vascular and the subsequent creation of Euphrates Vascular. For more information, contact CEO Sean Morris.

Flow is Life

The Future in Treating

Vascular Occlusions

ICHOR: Percutaneous Reperfusion System

Designed to treat Acute Limb Ischemia (ALI), organized thrombus and other embolic/thrombotic events

ICHOR has developed a one size fits all system that replicates the parameters of surgical embolectomy with reduced surgical or drug complications, no blood loss to aspiration, reduced bleeding complications associated with drug therapy, and eliminates the need for general anesthesia. The technology is easily adoptable by interventionalists, incorporates health economics, and specifically designed to make ICHOR a first line therapy for physicians and hospitals.

ICHOR’s Panacea is a much needed technology

...for treating peripheral arterial disease (PAD) in the lower limbs. Current technologies do not deliver the desired therapeutic results, and I believe the Panacea technology can deliver conclusive therapy with a design that is both elegant and intuitive. Lack of reasonable therapies will make Panacea a go-to device”

- Dr. J A Mustapha, FACC, FSCAI, Entrepreneur

Pulse MED: Improved Blood Clot Dissolution

Nano-technology designed to target non-invasive therapy in Acute Ischemic Stroke (AIS) and other vascular occlusions

Pulse MED™ is an iron based nanoparticle influenced by external magnetic power designed to treat and diagnose conditions current technologies cannot reach. The nano size and magnetic power source can target non-invasive therapy into common diseased vasculature as well as the deepest and smallest vascular beds today’s technologies cannot even explore. This novel platform nano-technology will diagnose and/or treat a wide array of vascular occlusions in a way that is elegant yet revolutionary for physicians and patients.

Stroke:

In stroke, a blood vessel becomes obstructed. When the clot-busting drug is administered, the challenge is getting the medicine where it needs to go. Pulses MED™ (Magnetically-Enhanced Diffusion) overcomes this barrier with a process that may be significantly faster in reaching clots, and as a result, more effective in treating strokes.

Disruptive

Safe and effective products to treat vascular occlusions and achieve reperfusion

Innovative

Minimally invasive systems easily adoptable by physicians, hospitals, and office based labs

Improve Outcomes

Reduces or eliminates surgical and drug complications

Better Economics

Technologies aimed at transforming outcomes and the economics in treating vascular occlusions

What Physicians Say

“The ICHOR Panacea device exceeded my expectations in terms of bulk retrieval of organized thrombus, the ease of maneuvering the entire low profile system using rapid exchange technique, and the durability of the device in treating large clot burden.”

Vascular Interventional Radiologist, Tampa, FL

 

“The potential of MED in helping physicians to have further reach, to identify areas of flow hidden by traditional means and to translate in, around and through vascular occlusions could be transformative.”

Craig Walker, MD

Experienced Team

Leading scientific advisory board and team.

Patented Platform

Novel technologies with 5 U.S. patents, 3 International patents, and several patents pending.

NIH Awards

Completed National Institute of Health (NIH) Milestones, recently awarded several new NIH study grants.

News

Euphrates’ Ichor Featured in EV Today’s Thrombectomy Buyer’s Guide

Euphrates Vascular’s ICHOR Percutaneous Reperfusion System is included in EV Today’s Device Guide for Mechanical Thrombectomy/Thrombolysis. This helpful buyer’s guide includes: Sheath compatibilityGuidewire compatibilityWorking lengthMode of operationUS FDA indicated use View EV Today’s Thrombectomy Guide

Read More

Are you ready to 
Make a Difference?